Identification of fetal unmodified and 5-hydroxymethylated CGs in maternal cell-free DNA for non-invasive prenatal testing. Identification of fetal unmodified and 5-hydroxymethylated CGs in maternal cell-free DNA for non-invasive prenatal testing

胎儿DNA表观遗传标记

Massively parallel sequencing of maternal cell-free DNA (cfDNA) is widely used to test fetal genetic abnormalities in non-invasive prenatal testing (NIPT). However, sequencing-based approaches are sti

NIAID Data Ecosystem40

Pregnant women’s information preferences after undergoing NIPT.

无创产前检测

围产期健康沟通

Pregnant women’s information preferences after undergoing NIPT.

Figshare2016-05-20 更新20

Supporting scripts for "Detection of Fetal Subchromosomal Abnormalities by Sequencing Circulating Cell-Free DNA from Maternal Plasma"

无创产前检测

胎儿染色体异常分析

These are the supporting scripts for the "Detection of Fetal Subchromosomal Abnormalities by Sequencing Circulating Cell-Free DNA from Maternal Plasma" manuscript

Figshare2016-01-18 更新10

Supporting scripts for "Detection of Fetal Subchromosomal Abnormalities by Sequencing Circulating Cell-Free DNA from Maternal Plasma"

资源简介：

相关数据集